These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33495415)

  • 1. Screening of Alzheimer's disease by facial complexion using artificial intelligence.
    Umeda-Kameyama Y; Kameyama M; Tanaka T; Son BK; Kojima T; Fukasawa M; Iizuka T; Ogawa S; Iijima K; Akishita M
    Aging (Albany NY); 2021 Jan; 13(2):1765-1772. PubMed ID: 33495415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of artificial intelligence to aid early detection of dementia: A scoping review on current capabilities and future directions.
    Li R; Wang X; Lawler K; Garg S; Bai Q; Alty J
    J Biomed Inform; 2022 Mar; 127():104030. PubMed ID: 35183766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of facial expression of fetuses by artificial intelligence (AI).
    Miyagi Y; Hata T; Bouno S; Koyanagi A; Miyake T
    J Perinat Med; 2021 Jun; 49(5):596-603. PubMed ID: 33548168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
    Brodaty H; Moore CM
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Digital Tree Drawing Test for Screening of Early Dementia: An Explorative Study Comparing Healthy Controls, Patients with Mild Cognitive Impairment, and Patients with Early Dementia of the Alzheimer Type.
    Robens S; Heymann P; Gienger R; Hett A; Müller S; Laske C; Loy R; Ostermann T; Elbing U
    J Alzheimers Dis; 2019; 68(4):1561-1574. PubMed ID: 30909229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Artificial Intelligence-Assisted Method for Dementia Detection Using Images from the Clock Drawing Test.
    Amini S; Zhang L; Hao B; Gupta A; Song M; Karjadi C; Lin H; Kolachalama VB; Au R; Paschalidis IC
    J Alzheimers Dis; 2021; 83(2):581-589. PubMed ID: 34334396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informant questionnaire on cognitive decline in the elderly (IQCODE) for assessing the severity of dementia in patients with Alzheimer's disease.
    Ding Y; Niu J; Zhang Y; Liu W; Zhou Y; Wei C; Liu Y
    BMC Geriatr; 2018 Jun; 18(1):146. PubMed ID: 29914396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hopkins Verbal Learning Test and screening for dementia.
    Hogervorst E; Combrinck M; Lapuerta P; Rue J; Swales K; Budge M
    Dement Geriatr Cogn Disord; 2002; 13(1):13-20. PubMed ID: 11731710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Deep Convolutional Neural Network-based algorithm for detection of diabetic retinopathy - Artificial intelligence versus clinician for screening.
    Shah P; Mishra DK; Shanmugam MP; Doshi B; Jayaraj H; Ramanjulu R
    Indian J Ophthalmol; 2020 Feb; 68(2):398-405. PubMed ID: 31957737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Beneficial Effect of Makeup Therapy on Cognitive Function of Dementia and Facial Appearance Analyzed by Artificial Intelligence Software.
    Tadokoro K; Yamashita T; Sato J; Omote Y; Takemoto M; Morihara R; Nishiura K; Tani T; Abe K
    J Alzheimers Dis; 2022; 85(3):1189-1194. PubMed ID: 34924394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Brief Memory and Executive Test (BMET): A cognitive screening tool to detect and differentiate vascular cognitive impairment and Alzheimer's disease.
    Hollocks MJ; Brookes RL; Morris RG; Markus HS
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):e273-e279. PubMed ID: 28881062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrimination ability of the Short Test of Mental Status (STMS) compared to the Mini Mental State Examination (MMSE) in the spectrum of normal cognition, mild cognitive impairment, and probable Alzheimer's disease dementia: The Turkish standardization study.
    Çebi M; Babacan G; Öktem Tanör Ö; Gürvit H
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):450-458. PubMed ID: 32406297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classifying Mild Cognitive Impairment from Behavioral Responses in Emotional Arousal and Valence Evaluation Task - AI Approach for Early Dementia Biomarker in Aging Societies.
    Rutkowski TM; Abe MS; Koculak M; Otake-Matsuura M
    Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():5537-5543. PubMed ID: 33019233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The estimation of premorbid intelligence levels in French speakers].
    Mackinnon A; Mulligan R
    Encephale; 2005; 31(1 Pt 1):31-43. PubMed ID: 15971638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we reduce the workload of mammographic screening by automatic identification of normal exams with artificial intelligence? A feasibility study.
    Rodriguez-Ruiz A; Lång K; Gubern-Merida A; Teuwen J; Broeders M; Gennaro G; Clauser P; Helbich TH; Chevalier M; Mertelmeier T; Wallis MG; Andersson I; Zackrisson S; Sechopoulos I; Mann RM
    Eur Radiol; 2019 Sep; 29(9):4825-4832. PubMed ID: 30993432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.